Chevy Chase Trust Holdings Inc. lowered its position in Xylem Inc. (NYSE:XYL) by 2.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 149,645 shares of the company’s stock after selling 3,300 shares during the period. Chevy Chase Trust Holdings Inc. owned 0.08% of Xylem worth $7,849,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Nisa Investment Advisors LLC increased its position in shares of Xylem by 1.7% in the second quarter. Nisa Investment Advisors LLC now owns 51,631 shares of the company’s stock valued at $2,305,000 after buying an additional 860 shares during the last quarter. MAI Capital Management acquired a new position in shares of Xylem during the second quarter valued at approximately $210,000. Capstone Asset Management Co. increased its position in shares of Xylem by 7.1% in the second quarter. Capstone Asset Management Co. now owns 13,959 shares of the company’s stock valued at $623,000 after buying an additional 930 shares during the last quarter. Hall Laurie J Trustee increased its position in shares of Xylem by 4.8% in the second quarter. Hall Laurie J Trustee now owns 10,450 shares of the company’s stock valued at $491,000 after buying an additional 475 shares during the last quarter. Finally, Creative Planning increased its position in shares of Xylem by 17.2% in the second quarter. Creative Planning now owns 13,634 shares of the company’s stock valued at $609,000 after buying an additional 2,001 shares during the last quarter. 86.38% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Xylem Inc. (NYSE:XYL) traded down 0.261% during trading on Tuesday, hitting $51.505. The company’s stock had a trading volume of 1,011,307 shares. Xylem Inc. has a 12 month low of $31.67 and a 12 month high of $54.99. The firm has a 50 day moving average of $50.32 and a 200 day moving average of $48.42. The firm has a market cap of $9.24 billion, a P/E ratio of 28.582 and a beta of 1.18.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, November 1st. The company reported $0.54 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.53 by $0.01. The company had revenue of $897 million for the quarter, compared to analysts’ expectations of $913.53 million. Xylem had a return on equity of 16.38% and a net margin of 8.83%. Xylem’s revenue for the quarter was down .6% compared to the same quarter last year. During the same period last year, the firm posted $0.49 EPS. Equities research analysts predict that Xylem Inc. will post $2.04 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 7th. Investors of record on Wednesday, November 9th will be issued a dividend of $0.1549 per share. The ex-dividend date is Monday, November 7th. This represents a $0.62 dividend on an annualized basis and a dividend yield of 1.20%. Xylem’s dividend payout ratio is 34.44%.

WARNING: “Chevy Chase Trust Holdings Inc. Cuts Stake in Xylem Inc. (XYL)” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2016/11/29/chevy-chase-trust-holdings-inc-cuts-stake-in-xylem-inc-xyl.html.

Several research analysts have commented on XYL shares. Atlantic Securities raised Xylem from a “neutral” rating to an “overweight” rating and set a $54.00 target price for the company in a research note on Monday, August 22nd. Royal Bank Of Canada boosted their price target on Xylem from $47.00 to $51.00 and gave the stock an “outperform” rating in a report on Tuesday, August 16th. Boenning Scattergood cut Xylem from an “outperform” rating to a “neutral” rating in a report on Monday. Janney Montgomery Scott upgraded Xylem from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $50.00 to $52.00 in a report on Wednesday, November 2nd. Finally, Northcoast Research began coverage on Xylem in a report on Thursday, November 17th. They set a “buy” rating on the stock. Eight investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Xylem presently has an average rating of “Buy” and an average target price of $47.15.

In other Xylem news, insider Colin R. Sabol sold 27,473 shares of Xylem stock in a transaction that occurred on Thursday, September 8th. The stock was sold at an average price of $50.91, for a total value of $1,398,650.43. Following the transaction, the insider now directly owns 65,530 shares of the company’s stock, valued at approximately $3,336,132.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Claudia S. Toussaint sold 5,300 shares of Xylem stock in a transaction that occurred on Friday, November 4th. The stock was sold at an average price of $47.27, for a total value of $250,531.00. Following the completion of the transaction, the senior vice president now directly owns 44,033 shares in the company, valued at $2,081,439.91. The disclosure for this sale can be found here. Corporate insiders own 0.77% of the company’s stock.

About Xylem

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

5 Day Chart for NYSE:XYL

Receive News & Stock Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related stocks with our FREE daily email newsletter.